Cytokinetics Inc (CYTK)

(19% Negative) Cytokinetics, Incorporated (CYTK) Announces Delay in Specified Development Timeline Due to Pandemic-Related Challenges, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment